Pierluigi Antonelli
Corporate Officer/Principal chez FRESENIUS SE & CO. KGAA
Profil
Pierluigi Antonelli is currently the Chief Executive Officer-Fresenius Kabi at Fresenius SE & Co. KGaA.
He is also the President & Chief Executive Officer at Fresenius Kabi AG.
Previously, he served as the Chief Executive Officer at Aziende Chimiche.
Riunite Angelini Francesco - A.C.R.A.F.
- SpA and Angelini Pharma, Inc. He was also the European Vice President & Managing Director-Italy at Bristol-Myers Squibb GmbH & Co. KGaA and Head-Europe Novartis Oncology at Sandoz Deutschland GmbH.
Earlier in his career, he worked as an Engagement Manager at Mckinsey & Co., Inc. (Munich) and Senior Vice President-Italy at Merck & Co. Mr. Antonelli holds an MBA degree from Northwestern University and an undergraduate degree from The LUISS University of Rome.
Postes actifs de Pierluigi Antonelli
| Sociétés | Poste | Début |
|---|---|---|
| FRESENIUS SE & CO. KGAA | Corporate Officer/Principal | 01/03/2023 |
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Chief Executive Officer | - |
Anciens postes connus de Pierluigi Antonelli
| Sociétés | Poste | Fin |
|---|---|---|
Angelini Pharma SpA
 Angelini Pharma SpA Miscellaneous Commercial ServicesCommercial Services Angelini Pharma SpA is an Italian pharmaceutical company that focuses on researching and developing medicines and pharmaceutical products. The private company is based in Rome, Italy. The company was founded in 1919. Jacopo Andreose has been the CEO of the company since 2023. | Chief Executive Officer | 06/02/2023 |
Sandoz Deutschland GmbH
 Sandoz Deutschland GmbH Financial ConglomeratesFinance Part of Novartis AG, Novartis Deutschland GmbH is an investment holding German company. The private company is based in Nuremberg, Germany. | Corporate Officer/Principal | 01/01/2019 |
| Mckinsey & Co., Inc. (Munich) | Corporate Officer/Principal | 01/01/1998 |
Bristol-Myers Squibb GmbH & Co. KGaA
 Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The private company is based in Munich, Germany. The CEO of the company is Han Steutel. | Corporate Officer/Principal | - |
| Merck & Co. | Corporate Officer/Principal | - |
Formation de Pierluigi Antonelli
| Northwestern University | Masters Business Admin |
| The LUISS University of Rome | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FRESENIUS SE & CO. KGAA | Health Technology |
| Entreprise privées | 8 |
|---|---|
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Health Technology |
Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA
 Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA Pharmaceuticals: OtherHealth Technology Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA engages in the design, marketing, and distribution of pharmaceuticals for health and wellness. It specializes in developing therapies for pain and inflammatory disorders, diseases and disorders of the nervous system, infection control, and infectious diseases. The company was founded by Francesco Angelini in 1941 and is headquartered in Rome, Italy. | Health Technology |
Sandoz Deutschland GmbH
Sandoz Deutschland GmbH Financial ConglomeratesFinance Part of Novartis AG, Novartis Deutschland GmbH is an investment holding German company. The private company is based in Nuremberg, Germany. | Finance |
| Mckinsey & Co., Inc. (Munich) | |
Angelini Pharma, Inc.
 Angelini Pharma, Inc. Specialty StoresRetail Trade Angelini Pharma, Inc. operates as a medical supply store. The company is headquartered in Rockville, MD. | Retail Trade |
| Merck & Co. | Finance |
Angelini Pharma SpA
Angelini Pharma SpA Miscellaneous Commercial ServicesCommercial Services Angelini Pharma SpA is an Italian pharmaceutical company that focuses on researching and developing medicines and pharmaceutical products. The private company is based in Rome, Italy. The company was founded in 1919. Jacopo Andreose has been the CEO of the company since 2023. | Commercial Services |
Bristol-Myers Squibb GmbH & Co. KGaA
Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The private company is based in Munich, Germany. The CEO of the company is Han Steutel. | Health Technology |
